AR and neoplasm: Disruption of the AR interaction with coactivators such as the BET bromodomain family protein, the BRD4 methyltransferase complex, and the MLL-Menin, DNA repair enzymes—DNA-PKcs, have shown promising results in attenuating AR signaling and tumor growth in CRPC (76, 79, 80).